1 Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women Journal of Clinical Endocrinology and Metabolism, May 8, 2013
2 Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Childrens Oncology Group phase 1 consortium study The Lancet Oncology, April 24, 2013
3 Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial The Lancet, May 16, 2013
4 Update on the Antimicrobial Management of Foot Infections in Patients With Diabetes Clinical Diabetes, April 18, 2013 Review Article
5 A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the cancer and osteoporosis research with alendronate and leuprolide (coral) study European Urology, May 2, 2013
6 Vitamin D and systemic lupus erythematosus: an update Expert Review of Clinical Immunology, May 9, 2013 Review Article
7 Bone Alkaline Phosphatase in CKD-Mineral Bone Disorder American Journal of Kidney Diseases, April 26, 2013
8 Prevalence and Predictors of Low Bone Mineral Density in Males with Ulcerative Colitis Journal of Clinical Endocrinology and Metabolism, April 18, 2013
9 The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis Osteoporosis International, April 22, 2013 Review Article
10 Risk of Metabolic Bone Disease is Increased Both during and after Weaning off Parenteral Nutrition in Pediatric Intestinal Failure Hormone Research in Paediatrics, April 26, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor